Company Filing History:
2 out of 854 
1 out of 1,505 
1 out of 145 
Years Active: 2002-2011
Title: Mary Anne Cotter: Innovator in Medical Science
Introduction
Mary Anne Cotter is a distinguished inventor based in Aberdeen, GB. She has made significant contributions to the field of medical science, particularly in the treatment of diabetic complications. With a total of 4 patents to her name, her work has had a profound impact on healthcare.
Latest Patents
Among her latest patents is a method for inhibiting microvascular complications by administering IL-6. This invention relates to the use of IL-6 or its derivatives in addressing microvascular complications. Another notable patent involves the use of 3-hydroxy-3-methylgutaryl coenzyme A reductase inhibitors for the manufacture of a medicament aimed at treating diabetic neuropathy. This invention highlights a new application of statin drugs to improve nerve conduction velocity and blood flow in diabetic patients, particularly when combined with other agents known to enhance diabetic neuropathy.
Career Highlights
Mary Anne Cotter has worked with prominent companies in the pharmaceutical industry, including Zeneca Limited and AstraZeneca AB. Her experience in these organizations has allowed her to develop innovative solutions that address critical health issues.
Collaborations
Throughout her career, Mary Anne has collaborated with notable professionals in her field, including Norman Cameron and Frank Carey. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Mary Anne Cotter's contributions to medical science through her patents and collaborations demonstrate her commitment to improving healthcare outcomes. Her innovative work continues to inspire advancements in the treatment of diabetic complications.